Patent ID: 8198314

Claim:
A method for the treatment of a disease selected from the group consisting of allergic asthma, perennial allergic rhinitis, seasonal allergic rhinitis, atopic dermatitis, contact hypersensitivity, conjunctivitis, allergic conjunctivitis, eosinophilic bronchitis, food allergies, eosinophilic gastroenteritis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, mastocytosis, hyper IgE syndrome, systemic lupus erythematosus, acne, multiple sclerosis, allograft rejection, chronic obstructive pulmonary disease, rheumatoid arthritis, psoriatic arthritis and osteoarthritis, comprising administering to a patient in need of such treatment an effective amount of a compound of general formula (I): wherein R 1 , R 3 and R 4 are hydrogen; R 2 is halo; R 5 and R 6 are hydrogen; R 7 is C 1 -C 6 alkyl; R 8 is a phenyl, naphthalenyl, thiazole, biphenyl, quinolinyl or quinoxalinyl group, any of which may be substituted with one or more halo, C 1 -C 6 alkyl, —O(C 1 -C 6 )alkyl, —SO 2 R 11 , or —OH groups; wherein R 11 is independently hydrogen or C 1 -C 6 alkyl; R 9 is hydrogen; or a pharmaceutically acceptable salt thereof.